Ginsenoside F1-Mediated Telomere Preservation Delays Cellular Senescence

Int J Mol Sci. 2023 Sep 19;24(18):14241. doi: 10.3390/ijms241814241.

Abstract

Telomeres play pivotal roles in processes closely related to somatic senescence and aging, making them a compelling target for interventions aimed at combating aging and age-related pathologies. Ginsenoside, a natural compound, has emerged as a potential remedy for promoting healthy aging, yet how it protects telomeres remains incompletely understood. Here, we show that treatment of F1 can effectively restore the level of TRF2, thereby preserving telomere integrity. This restoration leads to inhibition of the DNA damage response and improvements in mitochondrial function and, ultimately, delays in cellular senescence. Conversely, depletion of TRF2 causes mitochondrial dysfunction, accompanied by increased oxidative stress, autophagy inhibition, insufficient energy metabolism, and the onset of cellular senescence. These observations underscore the critical role of TRF2 in maintaining telomere integrity and direct association with the initiation of cellular senescence. We conduct a further analysis, suggesting F1 could bind in proximity to the TRF2 heterodimer interface, potentially enhancing dimerization stability. These findings suggest that F1 may be a promising natural remedy for anti-aging, and restoring TRF2 could potentially prevent telomere-dependent diseases commonly associated with the aging process.

Keywords: TRF2; ginsenoside F1; mitochondria; oxidative stress; senescence.

MeSH terms

  • Cellular Senescence
  • Ginsenosides* / pharmacology
  • Humans
  • Preservation, Biological
  • Syndrome

Substances

  • ginsenoside F1
  • Ginsenosides